Your session is about to expire
← Back to Search
Partially Hydrolyzed Whey Protein-Based Formula
Study Infant Formula for Gastrointestinal Tolerance
N/A
Waitlist Available
Research Sponsored by Abbott Nutrition
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up sday 1 to sday 28
Awards & highlights
Study Summary
This study is evaluating whether a formula with a different protein source and different carbohydrate content can reduce symptoms of formula intolerance in healthy infants.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ sday 1 to sday 28
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~sday 1 to sday 28
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Fussiness
Secondary outcome measures
Gastrointestinal Tolerance
Stool
Other outcome measures
Adverse Events
Formula Intake
Formula Satisfaction Questionnaire
+5 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Study Infant FormulaExperimental Treatment1 Intervention
Feed ad libitum during study period
Find a Location
Who is running the clinical trial?
Abbott NutritionLead Sponsor
168 Previous Clinical Trials
33,486 Total Patients Enrolled
John Lasekan, PhD, MS, MBA, CCRPStudy ChairAbbott Nutrition
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger